Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Designing a Sequence-Based Method for Identifying 14 High-Risk Carcinogenic HPV Types in Multiple Infections

Author(s): Arezou Alimardani, Narges Dastmalchi, Hamzeh Rahimi and Reza Safaralizadeh*

Volume 22, Issue 3, 2022

Published on: 18 February, 2022

Article ID: e270122200585 Pages: 17

DOI: 10.2174/1871526522666220127115120

Price: $65

conference banner
Abstract

Background: HPV tests have significant drawbacks in terms of detecting and differentiating types of the virus. PCR techniques provide timely and necessary results for patient care with high quality, sensitivity, and reasonable cost.

Methods: The sensitivity of PCR depends on the primers. In this study, a method was designed that exploited PCR with designed primers (ScTd) by changing the annealing temperature (Ta) along with Sanger sequencing for pap smear samples. Sanger sequencing has confirmed that ScTd primers have a relative differentiation power using PCR. The primers caused a relative differentiation by PCR. In the pap smear sample 22 with contamination of types 16, 31, and 45, confirmed by dot blot hybridization, type 16 was not amplified at the specific Ta. Moreover, the band was observed at low Ta.

Results: Sanger sequencing showed that type 16 was detected instead of type 52. Sequencing the heterozygous bands in multiple infections also led to the identification of different types. Moreover, with a combination of 7 pairs of primers, HPV types can be detected in multiple infections by PCR.

Conclusion: As compared with the clinical dot blot hybridization technique, the utilization of complementary PCR and sequencing methods with designed primers can provide a higher positive predictive value in the detection of high-risk types.

Keywords: HPV, Cervical cytology screening, ScTd primers, annealing temperature (Ta), lesions, carcinogenicity.

Graphical Abstract

[1]
Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: Addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009; 4: 8.
[http://dx.doi.org/10.1186/1750-9378-4-8] [PMID: 19486508]
[2]
Van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papillomaviruses: Correlation with clinical manifestations. J Gen Virol 1992; 73(Pt 10): 2653-60.
[http://dx.doi.org/10.1099/0022-1317-73-10-2653] [PMID: 1328477]
[3]
Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005; 32(Suppl. 1): S1-6.
[http://dx.doi.org/10.1016/j.jcv.2004.10.021]
[4]
de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324(1): 17-27.
[http://dx.doi.org/10.1016/j.virol.2004.03.033] [PMID: 15183049]
[5]
Villa LL, Denny L. CHAPTER 7 methods for detection of HPV infection and its clinical utility. Int J Gynaecol Obstet 2006; 94(Suppl. 1): S71-80.
[http://dx.doi.org/10.1016/S0020-7292(07)60013-7] [PMID: 29644640]
[6]
Boulet GA, Horvath CA, Berghmans S, Bogers J. Human papillomavirus in cervical cancer screening: Important role as biomarker. Cancer Epidemiol Biomarkers Prev 2008; 17(4): 810-7.
[http://dx.doi.org/10.1158/1055-9965.EPI-07-2865] [PMID: 18398022]
[7]
Yi X, Li J, Yu S, et al. A new PCR-based mass spectrometry system for high-risk HPV, part I: Methods. Am J Clin Pathol 2011; 136(6): 913-9.
[http://dx.doi.org/10.1309/AJCPWTZDT0Q7DOVI] [PMID: 22095377]
[8]
Karlsen F, Kalantari M, Jenkins A, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996; 34(9): 2095-100.
[http://dx.doi.org/10.1128/jcm.34.9.2095-2100.1996] [PMID: 8862564]
[9]
Watson RA. Human papillomavirus: Confronting the epidemic-A urologist’s perspective. Rev Urol 2005; 7(3): 135-44.
[PMID: 16985824]
[10]
Zappacosta R, Rosini S. Cervical cancer screening: From molecular basis to diagnostic practice, going through new technologies. Technol Cancer Res Treat 2008; 7(3): 161-74.
[http://dx.doi.org/10.1177/153303460800700302] [PMID: 18473488]
[11]
Meisal R, Rounge TB, Christiansen IK, et al. HPV genotyping of modified general primer-amplicons is more analytically sensitive and specific by sequencing than by hybridization. PLoS One 2017; 12(1): e0169074.
[http://dx.doi.org/10.1371/journal.pone.0169074] [PMID: 28045981]
[12]
Söderlund-Strand A, Carlson J, Dillner J. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J Clin Microbiol 2009; 47(3): 541-6.
[http://dx.doi.org/10.1128/JCM.02007-08] [PMID: 19144817]
[13]
Yin L, Yao J, Chang K, et al. HPV population profiling in healthy men by next-generation deep sequencing coupled with HPV-QUEST. Viruses 2016; 8(2): E28.
[http://dx.doi.org/10.3390/v8020028] [PMID: 26821041]
[14]
Mamanova L, Coffey AJ, Scott CE, et al. Target-enrichment strategies for next-generation sequencing. Nat Methods 2010; 7(2): 111-8.
[http://dx.doi.org/10.1038/nmeth.1419] [PMID: 20111037]
[15]
Eijkelenboom A, Kamping EJ, Kastner-van Raaij AW, et al. Reliable next-generation sequencing of formalin-fixed, paraffin-embedded tissue using single molecule tags. JMD 2016; 18(6): 851-63.
[http://dx.doi.org/10.1016/j.jmoldx.2016.06.010] [PMID: 27637301]
[16]
Akhras MS, Unemo M, Thiyagarajan S, et al. Connector inversion probe technology: A powerful one-primer multiplex DNA amplification system for numerous scientific applications. PLoS One 2007; 2(9): e915.
[http://dx.doi.org/10.1371/journal.pone.0000915] [PMID: 17878950]
[17]
Hardenbol P, Banér J, Jain M, et al. Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat Biotechnol 2003; 21(6): 673-8.
[http://dx.doi.org/10.1038/nbt821] [PMID: 12730666]
[18]
Boyle EA, O’Roak BJ, Martin BK, Kumar A, Shendure J. MIPgen: Optimized modeling and design of molecular inversion probes for targeted resequencing. Bioinformatics 2014; 30(18): 2670-2.
[http://dx.doi.org/10.1093/bioinformatics/btu353] [PMID: 24867941]
[19]
Hiatt JB, Pritchard CC, Salipante SJ, O’Roak BJ, Shendure J. Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res 2013; 23(5): 843-54.
[http://dx.doi.org/10.1101/gr.147686.112] [PMID: 23382536]
[20]
de Villiers EM. Laboratory techniques in the investigation of human papillomavirus infection. Genitourin Med 1992; 68(1): 50-4.
[http://dx.doi.org/10.1136/sti.68.1.50] [PMID: 1312507]
[21]
Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005; 32(Suppl. 1): S43-51.
[22]
Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37(8): 2508-17.
[http://dx.doi.org/10.1128/JCM.37.8.2508-2517.1999] [PMID: 10405393]
[23]
Parfenov M, Pedamallu CS, Gehlenborg N, et al. Cancer Genome Atlas Network. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci USA 2014; 111(43): 15544-9.
[http://dx.doi.org/10.1073/pnas.1416074111] [PMID: 25313082]
[24]
McBride AA, Warburton A. The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog 2017; 13(4): e1006211.
[http://dx.doi.org/10.1371/journal.ppat.1006211] [PMID: 28384274]

Rights & Permissions Print Cite
Article Metrics
17
1
© 2024 Bentham Science Publishers | Privacy Policy